These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6405769)

  • 1. The double-blind assessment of the effect of dihydro ergocryptine on muscle blood flow in normal human volunteer subjects.
    James IM; Burgoyne W
    Br J Clin Pharmacol; 1983 Jan; 15(1):123-5. PubMed ID: 6405769
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effects of atenolol, sotalol and labetalol on muscle blood flow in man.
    Raman GV; Mwongera FM; Warren DJ
    Postgrad Med J; 1986 Sep; 62(731):841-4. PubMed ID: 2880341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of treatment on performance and self-appraisal in geriatric patients (author's transl)].
    Oswald WD; Lang E
    MMW Munch Med Wochenschr; 1980 Jan; 122(2):59-62. PubMed ID: 6767923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of naftidrofuryl on macro-, microcirculation, tissue oxygen supply and flow properties of blood].
    Kiesewetter H; Jung F
    Vasa Suppl; 1990; 30():79-83. PubMed ID: 2075596
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ergoloid mesylate dihydroergotoxine: radioimmunoassay measurements on plasma and blood-pressure-lowering activity.
    Woodcock BG; Habedank WD; Loh W; Rietbrock N
    J Cardiovasc Pharmacol; 1984; 6(3):543-5. PubMed ID: 6202984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of adrenaline-potentiated thrombin-induced reaction of human blood platelets by dihydroergotoxine.
    Barthel W; Hoffmann A; Markwardt F
    Acta Biol Med Ger; 1978; 37(7):1073-9. PubMed ID: 747039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of naftidrofuryl on macro- and microcirculation, tissue oxygen supply and blood rheology].
    Jung F; Kiesewetter H
    Vasa Suppl; 1989; 27():38. PubMed ID: 2696110
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of acute oral beta adrenergic blockade on muscle blood flow in man.
    Smith RS; Warren DJ
    Cardiovasc Res; 1982 Apr; 16(4):205-8. PubMed ID: 6125262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans].
    Mercuro G; Rossetti Z; Rivano AC; Tocco L; Ruscazio M; Stefanini E; Gessa GL; Cherchi A
    Cardiologia; 1987 Jul; 32(7):643-50. PubMed ID: 3690588
    [No Abstract]   [Full Text] [Related]  

  • 11. Muscle blood flow in normal subjects and in patients with intermittent claudication of the legs.
    Amery A; Bossaert H; Verstraete M; De Roo M
    Acta Cardiol; 1969; 24(2):170-83. PubMed ID: 5308539
    [No Abstract]   [Full Text] [Related]  

  • 12. [The action of dihydroergotoxine in acute sickling crisis. Results of a double-blind study carried out in French speaking Africa (author's transl)].
    Begue P; Bertrand E; Bonhomme J; David M; Coullet Y; Pierredon M; Sankale M
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2449-52. PubMed ID: 358140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dihydroergotoxine on activities of beta-receptor stimulators.
    Kitamura S; Ishihara Y; Sasaki K; Shimizu T; Harasawa M
    Arzneimittelforschung; 1977; 27(10):1959-61. PubMed ID: 21668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative plethysmographic study of the venoconstrictor effect of dihydroergotamine and dihydroergotoxine on the deep veins of the calf in healthy subjects and patients suffering from varicosis.
    Barthel W; Grossmann K
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):458-64. PubMed ID: 7141753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ergoloid mesylates and ECT.
    Sachs GS; Gelenberg AJ; Bellinghausen B; Wojcik J; Falk WE; Farhadi AM; Jenike M
    J Clin Psychiatry; 1989 Mar; 50(3):87-90. PubMed ID: 2647711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the effect of dihydroergocristin-methansulfonate on human cerebral blood flow in an acute test/studies with the intracarotid 133xenon clearance method (author's transl)].
    Kohlmeyer K; Blessing J
    Arzneimittelforschung; 1978; 28(10):1788-97. PubMed ID: 114183
    [No Abstract]   [Full Text] [Related]  

  • 17. A long-term study with co-dergocrine mesylate (Hydergine) in healthy pensioners. Results after 3 years.
    Köberle S; Spiegel R
    Gerontology; 1984; 30 Suppl 1():3-52. PubMed ID: 6489764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydergine in senile mental impairment.
    Loew DM; Weil C
    Gerontology; 1982; 28(1):54-74. PubMed ID: 7037548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dependence of hypoxic changes in macro- and micro-hemodynamics on the activity of adrenoreceptors in the skeletal muscle in hypothermia].
    Nurmatov AA; Kudriashov IuA; Tkachenko BI
    Biull Eksp Biol Med; 1989 Jan; 107(1):16-9. PubMed ID: 2536567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of oxygen and potassium on vascular resistance of dog skeletal muscle.
    Skinner NS; Powell WJ
    Am J Physiol; 1967 Mar; 212(3):533-40. PubMed ID: 6067005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.